This is preserved historical wording.
It is no longer the current profile. Read the current profile and its correction notice.
It is no longer the current profile. Read the current profile and its correction notice.
What this version reported
FDA's compounding-risk page says it has not identified human exposure data for drug products containing MOTS-c and lacks important safety information.↗
Organizations named in cited records:
- U.S. Food and Drug Administration↗
Sources for this version
- 1Certain bulk drug substances for use in compounding that may present significant safety risks ↗
U.S. Food and Drug Administration · Official source · Source checked July 29, 2026